GSK company, and its research study team claimed to have discovered a new chemical entity that protects against diet-induced obesity. It also improves glucose tolerance and insulin sensitivity and enhances exercise endurance by enhancing fat utilization in certain target tissues.
SRT1720 can be an answer to the problems of obesity and diabetes. After successful experiments on mice model, researchers are hopeful to use the same on the human subjects. The drug appears to increase energy levels when exercising. The drug mimics the effects of an ingredient in red wine.